# Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization

> **NCT03013647** · NA · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Methyl Aminolevulinate

## Key facts

- **NCT ID:** NCT03013647
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03013647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03013647, "Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03013647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*